Molina Healthcare (NYSE:MOH) Price Target Raised to $392.00

Molina Healthcare (NYSE:MOH) had its target price increased by equities researchers at JPMorgan Chase & Co. from $367.00 to $392.00 in a report released on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 9.22% from the stock’s current price.

A number of other research firms have also commented on MOH. Bank of America raised their price objective on shares of Molina Healthcare from $340.00 to $350.00 in a research note on Thursday, July 27th. Cantor Fitzgerald reiterated an “overweight” rating and set a $359.00 price target on shares of Molina Healthcare in a report on Thursday, September 14th. Stephens reissued an “equal weight” rating and set a $350.00 price target on shares of Molina Healthcare in a research report on Tuesday, October 3rd. Finally, StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $348.45.

Molina Healthcare Trading Down 1.8 %

Shares of NYSE MOH traded down $6.43 during mid-day trading on Friday, hitting $358.92. 73,472 shares of the company traded hands, compared to its average volume of 465,840. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.61. Molina Healthcare has a 1 year low of $256.19 and a 1 year high of $369.50. The stock has a market capitalization of $20.93 billion, a price-to-earnings ratio of 22.38, a PEG ratio of 1.20 and a beta of 0.57. The business has a 50 day moving average of $339.40 and a two-hundred day moving average of $312.98.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, October 25th. The company reported $5.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.87 by $0.18. Molina Healthcare had a return on equity of 34.85% and a net margin of 2.80%. The firm had revenue of $8.55 billion for the quarter, compared to the consensus estimate of $8.24 billion. During the same quarter in the previous year, the company earned $4.36 EPS. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Molina Healthcare will post 20.83 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Steven J. Orlando sold 1,134 shares of Molina Healthcare stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $325.96, for a total transaction of $369,638.64. Following the completion of the sale, the director now directly owns 19,299 shares in the company, valued at approximately $6,290,702.04. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CAO Maurice Hebert sold 692 shares of the company’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $328.15, for a total value of $227,079.80. Following the completion of the sale, the chief accounting officer now directly owns 8,528 shares in the company, valued at $2,798,463.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven J. Orlando sold 1,134 shares of the firm’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $325.96, for a total value of $369,638.64. Following the transaction, the director now owns 19,299 shares in the company, valued at $6,290,702.04. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Brighton Jones LLC lifted its stake in shares of Molina Healthcare by 1.0% in the second quarter. Brighton Jones LLC now owns 3,302 shares of the company’s stock worth $995,000 after buying an additional 33 shares during the last quarter. Captrust Financial Advisors boosted its holdings in Molina Healthcare by 0.5% during the second quarter. Captrust Financial Advisors now owns 6,315 shares of the company’s stock valued at $1,766,000 after acquiring an additional 33 shares during the period. New York Life Investment Management LLC grew its position in shares of Molina Healthcare by 0.4% in the first quarter. New York Life Investment Management LLC now owns 8,454 shares of the company’s stock valued at $2,261,000 after purchasing an additional 34 shares during the last quarter. Financial Gravity Asset Management Inc. increased its stake in shares of Molina Healthcare by 12.7% in the second quarter. Financial Gravity Asset Management Inc. now owns 301 shares of the company’s stock worth $12,106,000 after purchasing an additional 34 shares during the period. Finally, Aptus Capital Advisors LLC lifted its position in shares of Molina Healthcare by 5.0% during the 3rd quarter. Aptus Capital Advisors LLC now owns 763 shares of the company’s stock worth $250,000 after purchasing an additional 36 shares during the last quarter. Institutional investors and hedge funds own 98.11% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.